Intelligence · Clinical pipeline
Oncology · Phase I
Oncology programs at Phase I — ClinicalTrials.gov pipeline intelligence.
Programs 8
Quick answer
Oncology Phase I programs: NovaPharmaNews indexes 8 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Chinese Academy of 70 programs
- First People's Hospital 62 programs
- Takeda 49 programs
- United Therapeutics Europe 41 programs
- BEONE MEDICINES AUS 40 programs
- Regeneron UK 34 programs
- Anaxis Pharma 31 programs
- Chongqing Precision Biotech 27 programs
- Janssen-Cilag International N.V 27 programs
- Novartis India 27 programs
- Boehringer Ingelheim 24 programs
- BRIGHT MINDS BIOSCIENCES 23 programs
Pipeline programs
-
2018-523-00US1
Hutchmed Europe B.V.
Lymphoma
1 trial -
68Ga-FAPI-Biotin
The First People's Hospital of Lianyungang
Tumor
1 trial -
68Ga-Pentixafor
The First People's Hospital of Lianyungang
Lymphoma
1 trial -
Azenosertib
Zentalis Pharmaceuticals
Osteosarcoma
1 trial -
Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
Shanghai University of Traditional Chinese Medicine
Osteosarcoma
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Liposarcoma
1 trial -
The Chimeric Antigen Receptor T Cell Immunotherapy (CAR-T)
Sinobioway Cell Therapy Co.,
Lymphoma
1 trial -
ziv-aflibercept
Regeneron UK Limited
Lymphoma
2 trials
Frequently asked questions
How many oncology Phase I programs exist?
8 programs match both the therapeutic area and stage filters in our published index.